“I am a physician and specialist in diabetes, and I am a dedicated clinical investigator leading my team of research nurses and Fellows. I have been involved in the development of many novel diabetic compounds for the last 20 years, and our clinical research centre within the NHS trust where I work has participated in over 40 trials sponsored by the major pharmaceutical companies. I was pleased to be given the opportunity by MDCPartners to preview and evaluate the research breadth of their data mining project ‘ta-Scan’, with the objective to validate by expert review the innovative, automated approach to data collection and aggregation. I’ve reviewed the data on the development system, specifically on compounds for the treatment of diabetes and associated pathologies.”
The scope of data reviewed:
“In summary, the data offers a comprehensive insight in a wide therapeutic area. The system successfully segmented trials, researchers and research locations. I see the significance of this automatic data mining approach as an interesting tool to add structure to complex data pools and can see the practical benefit for sponsored pharmaceutical development.”